United States Aesthetic Devices Market Outlook to 2025 – Aesthetic Fillers and Aesthetic Implants

Powered by

All the vital news, analysis, and commentary curated by our industry experts.


GlobalData’s “United States Aesthetic Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Aesthetic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Aesthetic Fillers and Aesthetic Implants.

The United States Aesthetic Devices Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Aesthetic Devices Market.
• Global corporate-level profiles of key companies operating within the United States Aesthetic Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.


United States Aesthetic Devices is segmented as follows:

• Aesthetic Fillers

• Aesthetic Implants

Reasons to Buy

Key Reasons to Purchase – The United States Aesthetic Devices Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Aesthetic Devices Market Outlook to 2025” report:
• Allergan Ltd
• Mentor Worldwide LLC
• Merz Pharma GmbH & Co KgaA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Aesthetic Devices Market Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Aesthetic Devices Market, United States 9

3.1 Aesthetic Devices Market, United States, Revenue ($m), 2015-2025 9

3.1.1 Aesthetic Fillers Market, United States, Revenue ($m), by Segment, 2015-2025 11

3.1.2 Aesthetic Implants Market, United States, Revenue ($m), by Segment, 2015-2025 13

3.2 Aesthetic Devices Market, United States, Volume (Units), 2015-2025 15

3.2.1 Aesthetic Fillers Market, United States, Volume (Units), by Segment, 2015-2025 17

3.2.2 Aesthetic Implants Market, United States, Volume (Units), by Segment, 2015-2025 19

3.3 Aesthetic Devices Market, United States, Average Price ($), 2015-2025 21

3.4 Aesthetic Devices Market, United States, Distribution Share by Revenue ($m), 2019 23

3.5 Aesthetic Devices Market, United States, Company Share by Revenue ($m), 2019 24

4 Overview of Key Companies in United States, Aesthetic Devices Market 26

4.1 Allergan Ltd 26

4.1.1 Company Overview 26

4.2 Mentor Worldwide LLC 26

4.2.1 Company Overview 26

4.3 Merz Pharma GmbH & Co KgaA 26

4.3.1 Company Overview 26

4.4 Galderma SA 27

4.4.1 Company Overview 27

4.5 Boston Scientific Corp 27

4.5.1 Company Overview 27

4.6 Sientra Inc 27

4.6.1 Company Overview 27

4.7 Coloplast A/S 28

4.7.1 Company Overview 28

5 Aesthetic Devices Market Pipeline Products 29

6 Financial Deals Landscape 30

6.1 Equity Offerings 30

6.1.1 Cutera Raises USD28.8 Million in Public Offering of Shares 30

6.1.2 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 32

6.1.3 Establishment Labs Raises USD69 Million in Public Offering of Shares 33

6.1.4 Misonix Prices Public Offering of Shares for USD30 Million 35

6.1.5 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 37

6.1.6 InMode Aesthetic Solutions May Raise Funds through Public Offering of Shares 39

6.1.7 Avita Medical Raises USD15.4 Million in Private Placement of Shares 40

6.1.8 InMode Aesthetic Solutions Underwriters Exercise of Over-Allotment Option of IPO of Shares for USD77 Million 41

6.1.9 NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock 43

6.2 Partnerships 44

6.2.1 Suneva Medical Enters into Partnership with Sinclair Pharma 44

6.3 Private Equity 45

6.3.1 Clayton, Dubilier & Rice Acquires Cynosure from Hologic for USD205 Million 45

6.4 Venture Financing 47

6.4.1 Suneva Medical Raises USD25.1 Million in Venture Financing 47

6.4.2 Suneva Medical Raises USD5 Million in Venture Financing 48

6.4.3 Surgical Innovation Associates Raises USD4 Million in Series A Financing 49

6.4.4 Suneva Medical Raises USD2.5 Million in Venture Financing 50

7 Recent Developments 51

7.1 Corporate Communications 51

7.1.1 Mar 12, 2020: Plus Therapeutics welcomes two new Directors 51

7.1.2 Feb 06, 2020: Plus Therapeutics appoints Chief Financial Officer 51

7.1.3 Feb 06, 2020: Plus Therapeutics announces changes to its Board of Directors 52

7.1.4 Jan 07, 2020: Dyve Biosciences announces Chuck Harbert, Ph.D. to join as Chief Scientific Officer 52

7.1.5 Jan 02, 2020: Plus Therapeutics appoints Dr. An van Es-Johansson to board of directors 52

7.1.6 Dec 10, 2019: Sciton’s recent User Summit Held in Dallas broke new records 53

7.1.7 Dec 09, 2019: Diane Gomez-Thinnes appointed as worldwide president of mentor 54

7.1.8 Nov 18, 2019: Cutera appoints Fuad Ahmad as Interim CFO 55

7.1.9 Nov 13, 2019: Bausch + Lomb And TerraCycle announce donation of new custom training modules incorporating used contact lens Materials to Guide Dog Foundation 55

7.1.10 Nov 12, 2019: Merz forms fully focused global medical aesthetics business: Merz Aesthetics 56

7.1.11 Oct 24, 2019: Aspen Laser receives award from Global Health & Pharma 57

7.1.12 Aug 16, 2019: Merz announces key governance changes 57

7.1.13 Aug 12, 2019: Cutera announces planned retirement of David B. Apfelberg, M.D., as member of the board of directors 58

7.1.14 Jul 24, 2019: AirXpanders announces board changes 59

7.1.15 Jul 09, 2019: Cutera announces appointment of David Mowry as Chief Executive Officer 59

7.2 Financial Announcements 60

7.2.1 Feb 26, 2020: Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results 60

7.2.2 Feb 12, 2020: CHF solutions expands commercial presence in Europe with distribution arrangement for Germany, Austria and Switzerland 61

7.2.3 Jan 28, 2020: Establishment Labs announces preliminary results for fourth quarter and full year 2019; reports record revenue 62

7.2.4 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million 62

7.2.5 Jan 12, 2020: Cutera announces preliminary financial results for fourth quarter and full-year 2019 63

7.2.6 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 63

7.2.7 Nov 07, 2019: Cutera reports third quarter 2019 financial results 65

7.2.8 Sep 23, 2019: MOCA I acute heart attack data to be presented at TCT19 66

7.2.9 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 67

7.2.10 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results 69

7.2.11 Aug 08, 2019: Cutera reports second quarter 2019 financial results 71

7.3 Legal And Regulatory 72

7.3.1 Mar 10, 2020: Cutera claims Lutronic stole trade secrets 72

7.3.2 Dec 16, 2019: Bausch Health Resolves "Stock Drop" Litigation initially filed in October 2015 73

7.3.3 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 73

7.3.4 Jul 16, 2019: Candela and Lumenis announce settlement of patent infringement lawsuit 74

7.3.5 Jun 20, 2019: SEC investigation of Misonix ends with no action 74

7.4 Other Significant Developments 75

7.4.1 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes 75

7.4.2 Dec 16, 2019: Eclipse obtains major quality and regulatory milestone 75

7.5 Product News 76

7.5.1 Dec 04, 2019: Cartessa Aesthetics releases Subnovii Plasma Technology to the US Marketplace 76

7.5.2 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 76

7.5.3 Oct 17, 2019: Dyve Biosciences to present at the 2019 BIO Investor Forum 77

7.5.4 Oct 03, 2019: Dyve Biosciences to highlight the power and potential of transdermal drug delivery at PODD 2019 77

7.6 Strategy And Business Planning 77

7.6.1 Feb 03, 2020: Candela to market MT.DERM's medical microneedling products 77

7.6.2 Nov 21, 2019: Hologic to divest Cynosure medical aesthetics unit for $205m 78

7.6.3 Nov 12, 2019: BD submits Pre-Market approval supplement to FDA for BD Onclarity HPV Test with extended genotyping capabilities 78

8 Appendix 80

8.1 Research Methodology 81

8.1.1 Coverage 81

8.1.2 Secondary Research 81

8.1.3 Primary Research 82

8.1.4 Market Modeling and Forecasting 83

8.1.5 Company Share Analysis 85

8.1.6 Distribution Share Analysis 85

8.1.7 Benchmarking 85

8.2 GlobalData Consulting 86

8.3 Contact Us 86

8.4 Disclaimer 87

Frequently asked questions

United States Aesthetic Devices Market Outlook to 2025 – Aesthetic Fillers and Aesthetic Implants thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Aesthetic Devices Market Outlook to 2025 – Aesthetic Fillers and Aesthetic Implants in real time.

  • Access a live United States Aesthetic Devices Market Outlook to 2025 – Aesthetic Fillers and Aesthetic Implants dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.